Ignite Creation Date:
2025-12-24 @ 10:20 PM
Ignite Modification Date:
2025-12-25 @ 7:53 PM
Study NCT ID:
NCT05690035
Status:
WITHDRAWN
Last Update Posted:
2024-07-09
First Post:
2023-01-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Tislelizumab Combined With Fruquintinib for Metastatic pMMR/MSS Colorectal Cancer
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-10
First Submit QC Date:
None
Study First Post Date:
2023-01-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-05
Last Update Post Date:
2024-07-09
Last Update Post Date Type:
ACTUAL